Akero Therapeutics to Present at the Goldman Sachs 46th Annual Global Healthcare Conference — Neutral
AKRO GlobeNewsWire — June 03, 2025SOUTH SAN FRANCISCO, Calif., June 03, 2025 (GLOBE NEWSWIRE) -- Akero Therapeutics, Inc. (Nasdaq: AKRO), a clinical-stage company developing transformational treatments for patients with serious metabolic diseases marked by high unmet medical need, today announced that management will present at the Goldman Sachs 46th Annual Global Healthcare Conference on Tuesday, June 10, 2025, at 2:40 p.m. E.T.

Sanoke Viswanathan Appointed Chief Executive Officer Effective Early September 2025 Phil Snow to Retire After Accomplished 30-Year Career with FactSet, Including 10 Years as CEO NORWALK, Conn., June 03, 2025 (GLOBE NEWSWIRE) -- FactSet (NYSE: FDS | NASDAQ: FDS), a global financial digital platform and enterprise solutions provider, today announced that its Board of Directors has appointed Sanoke Viswanathan as Chief Executive Officer, effective early September 2025.

Monopar Therapeutics Announces Inclusion in the Russell 3000® and Russell 2000® Indexes — Neutral
MNPR GlobeNewsWire — June 03, 2025WILMETTE, Ill., June 03, 2025 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (“Monopar” or the “Company”) (Nasdaq: MNPR), a clinical‐stage biopharmaceutical company focused on developing innovative treatments for patients with unmet medical needs, today announced that it will be added to the broad-market Russell 3000® Index, with automatic inclusion in the small-cap Russell 2000® Index, after the close of U.S. equity markets on June 27, 2025.

GOTHENBURG, Sweden--(BUSINESS WIRE)--Polestar (Nasdaq: PSNY) announces that in conjunction with its Annual General Meeting (AGM) to be held in London on 30 June 2025, certain changes to the Company's Board of Directors are being submitted for shareholder approval. Full details of the AGM are available on the Company's Investor Relations website: https://investors.polestar.com/corporate-governance/annual-general-meeting Karen Francis' and Zhe (David) Wei's terms are ending at the closing of this.

Agenus and Zydus Lifesciences Enter $141M Strategic Collaboration to Advance BOT/BAL, Expand Zydus' Biologics Manufacturing in the US — Neutral
AGEN Business Wire — June 03, 2025LEXINGTON, Mass.--(BUSINESS WIRE)--Agenus Inc. (Nasdaq: AGEN), a leader in immuno-oncology innovation, today announced it has signed definitive partnership agreements with Zydus Lifesciences Ltd. (NSE: ZYDUSLIFE), including its subsidiaries/affiliates, hereafter referred to as “Zydus,” designed to accelerate clinical development, scale global manufacturing, and expand patient access to botensilimab and balstilimab (BOT/BAL). The strategic collaboration includes an exchange of Agenus' state-of-t.

Innoviva to Participate in Upcoming Investor Conferences — Neutral
INVA Business Wire — June 03, 2025BURLINGAME, Calif.--(BUSINESS WIRE)--Innoviva, Inc. (NASDAQ: INVA) (“Innoviva” or the “Company”), a diversified holding company with a core royalties portfolio, a leading critical care and infectious disease platform known as Innoviva Specialty Therapeutics (“IST”), and a portfolio of strategic investments in healthcare assets, today announced that management will participate in the following upcoming investor conferences in June: Goldman Sachs 46th Annual Global Healthcare Conference 2025 Form.

AMC Summer Movie Camp Returns to AMC Theatres® Beginning June 23 – Popular Family-Friendly Titles at a Significantly Discounted Price — Neutral
AMC Business Wire — June 03, 2025LEAWOOD, Kan.--(BUSINESS WIRE)--AMC Theatres® (NYSE:AMC), the largest theatrical exhibitor in the United States and the world, today announced that its annual AMC Summer Movie Camp program is returning to theatres for summer 2025. Throughout the summer, guests can enjoy family-friendly titles from DreamWorks Animation and Illumination at select AMC locations throughout the United States. A new title will be featured each week, with screenings offered on Mondays and Wednesdays at 11 a.m. and 2 p.

Amylyx Pharmaceuticals Receives U.S. FDA Fast Track Designation for AMX0114 for the Treatment of Amyotrophic Lateral Sclerosis — Neutral
AMLX Business Wire — June 03, 2025CAMBRIDGE, Mass.--(BUSINESS WIRE)---- $AMLX--Amylyx Pharmaceuticals Receives U.S. FDA Fast Track Designation for AMX0114 for the Treatment of Amyotrophic Lateral Sclerosis.

Metropolitan Washington Council of Governments Adds 908 Devices' XplorIR to Its Hazardous Materials Response Toolkit — Neutral
MASS Business Wire — June 03, 2025BOSTON--(BUSINESS WIRE)-- #chemID--908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld devices for chemical analysis, announces that the Metropolitan Washington Council of Governments (COG) has purchased eight XplorIR devices, one for each of the seven counties and District of Columbia, which comprise the COG. The devices were shipped in Q1 2025, with training taking place in Q2 2025. The handheld XplorIR device accurately detects, identifies, and quantifies 5,000 unknown gas and vapor c.

Davidson Instruments, Inc. sues Parker-Hannifin Corporation, alleging antitrust violations, theft of trade secrets, and copyright infringement and other acts due to fraudulent patent filings based on Davidson trade secrets — Neutral
PH Business Wire — June 03, 2025THE WOODLANDS, Texas--(BUSINESS WIRE)--Davidson Instruments, a world leader in the development of fiber optic pressure measurement systems for use in harsh industrial applications, alleges that Parker-Hannifin Corporation (NYSE: PH) is responsible for the filing of a fraudulent patent application in 2024, other fraudulent patent filings, and other acts of theft and misappropriation of Davidson's trade secrets. Davidson's trade secrets can eliminate greenhouse gas emissions and also maximize fue.

Ninety-Five Percent of Manufacturers Are Investing in AI to Navigate Uncertainty and Accelerate Smart Manufacturing — Neutral
ROK Business Wire — June 03, 2025MILWAUKEE--(BUSINESS WIRE)--Rockwell Automation, Inc. (NYSE: ROK), the world's largest company dedicated to industrial automation and digital transformation, today announced the results of the 10th annual “State of Smart Manufacturing Report.” The global study, fielded in March 2025, surveyed more than 1,500 manufacturers across 17 of the leading manufacturing countries. As manufacturers continue to face uncertainty driven by economic shifts, the report highlights how companies are turning to s.

Americas Gold and Silver Announces Transformational US$100 Million Debt Financing and Secures Multi-Metal Offtake Agreement for Galena Concentrates — Neutral
USAS Business Wire — June 03, 2025TORONTO--(BUSINESS WIRE)--Americas Gold and Silver Corporation (TSX: USA) (NYSE American: USAS) (“Americas” or the “Company”), a growing North American precious metals producer, is pleased to announce that it has arranged a US$100 million of senior secured debt facility ("Term Loan Facility”) to be provided by a third party to be used primarily to fund growth and development capital spending at the Galena Complex. The US$100 million Term Loan Facility consists of three tranches: a term loan wit.

Bruker Announces Acquisition of biocrates, a Leader in Mass Spectrometry-based Quantitative Metabolomics — Neutral
BRKR Business Wire — June 03, 2025INNSBRUCK, Austria--(BUSINESS WIRE)---- $BRKR #BRKR--Bruker Corporation (NASDAQ: BRKR) today announced the acquisition of biocrates life sciences ag, located in Innsbruck, Austria. Financial terms were not disclosed. biocrates is a global leader in mass spectrometry (MS)-based quantitative metabolite and lipid analysis kits, assays, software and services that make standardized metabolomics accessible to laboratories worldwide. The biocrates kits cover over 1,000+ metabolites from more than 40 metabolite classe.

Constellation, Meta Sign 20-Year Deal for Clean, Reliable Nuclear Energy in Illinois — Neutral
CEG Business Wire — June 03, 2025CLINTON, Ill.--(BUSINESS WIRE)--Constellation and Meta have signed a 20-year power purchase agreement for the emissions-free nuclear output of the Clinton Clean Energy Center.

ReposiTrak Adds 50 New Food and Beverage Suppliers to the Queue for the Rapidly Expanding Food Traceability Network — Neutral
TRAK Business Wire — June 03, 2025SALT LAKE CITY--(BUSINESS WIRE)--Retailers drive increased focus on food safety and traceability as 50 new suppliers enter the queue to join the ReposiTrak Traceability Network.

AMG Names Thomas M. Wojcik as President and Chief Operating Officer — Neutral
AMG GlobeNewsWire — June 03, 2025WEST PALM BEACH, Fla., June 03, 2025 (GLOBE NEWSWIRE) -- AMG, a strategic partner to leading independent investment management firms globally, today announced the appointment of Thomas M.

NEW YORK--(BUSINESS WIRE)--Accenture will host a conference call at 8:00 a.m. EDT on Friday, June 20, 2025, to discuss its third-quarter fiscal 2025 financial results.

Karooooo Is Scaling Efficiently In An Underpenetrated Market — Positive
KARO Seeking Alpha — June 03, 2025I reiterate my Buy rating on Karooooo as its telematics SaaS business delivers strong recurring revenue growth, robust margins, and record Q4 results. Karooooo's subscription model, high-growth end markets, and accelerating geographic expansion in SEA and Europe underpin my bullish investment thesis. Valuation remains attractive with a FWD PEG of ~1.0x, well below SaaS peers, offering meaningful upside if growth targets are met or exceeded.

Scorpio Tankers Q1 2025: Reducing Debt, Boosting Cash, And Still Undervalued — Positive
STNG Seeking Alpha — June 03, 2025Scorpio Tankers delivers strong Q1 2025 results, reducing debt, increasing cash, and rewarding shareholders with dividends and buybacks, all while maintaining minimal CAPEX. The fleet is modern, efficient, and well-positioned for changing market conditions, with stable charter rates and strategic investments enhancing cash flow. Despite sector cyclicality, Scorpio benefits from favorable macro trends, tight supply, and is undervalued compared to peers, trading below book value with high profitability.

Telix Investor Day in New York City on June 11, 2025: Presenting KOLs — Neutral
TLX GlobeNewsWire — June 03, 2025MELBOURNE, Australia and INDIANAPOLIS, June 03, 2025 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”, “the Company”) provides further details on the agenda for the Company's Investor Day to be held on Wednesday, June 11, 2025, at The Yale Club in New York City, from 8.30am ET (10.30pm AEST) to 12.00pm ET.
